Together, CXCL8 secreted by iGRANs that accumulate in the PB of CMML patients inhibits the growth of WT CD34+ cells while sparing CMML CD34+ cells in which CXCL8 receptors are downregulated. This evidence concerns the gene CD34 and chronic myelomonocytic leukemia.